| Thiazide use | p value | |||
---|---|---|---|---|---|
Yes (n = 4734) | No (n = 4734) | ||||
n | % | n | % | ||
Age (years) | 0.206 | ||||
 < 60 | 1454 | 30.7 | 1411 | 29.8 |  |
 60–79 | 2601 | 54.9 | 2684 | 56.7 | |
 ≥ 80 | 679 | 14.3 | 639 | 13.5 | |
Gender | 0.661 | ||||
 Male | 2776 | 58.6 | 2755 | 58.2 |  |
 Female | 1958 | 41.4 | 1979 | 41.8 | |
Income level (NTD) | 0.737 | ||||
 Financially dependent | 1281 | 27.1 | 1312 | 27.7 |  |
 1–19,999 | 2466 | 52.1 | 2464 | 52.1 | |
 20,000–39,999 | 646 | 13.7 | 641 | 13.5 | |
 ≥ 40,000 | 341 | 7.2 | 317 | 6.7 | |
Urbanization level | 0.809 | ||||
 1 (Most urbanized) | 1138 | 24.0 | 1148 | 24.3 |  |
 2 | 1242 | 26.2 | 1271 | 26.9 | |
 3 | 860 | 18.2 | 852 | 18.0 | |
 4 | 848 | 17.9 | 855 | 18.1 | |
 5 (Least urbanized) | 646 | 13.7 | 608 | 12.8 | |
Stroke type | 0.918 | ||||
 Ischemic | 2861 | 60.4 | 2864 | 60.5 |  |
 Hemorrhagic | 807 | 17.1 | 821 | 17.3 | |
 TIA | 617 | 13.0 | 596 | 12.6 | |
 Others | 449 | 9.5 | 453 | 9.6 | |
Charlson comorbidity index | 0.707 | ||||
 1–2 | 2936 | 62.0 | 2957 | 62.5 |  |
 3–4 | 1338 | 28.3 | 1304 | 27.5 | |
 ≥ 5 | 460 | 9.7 | 473 | 10.0 | |
Hypertension | 4268 | 90.2 | 4267 | 90.1 | 0.972 |
Diabetes mellitus | 1678 | 35.5 | 1663 | 35.1 | 0.747 |
COPD | 790 | 16.7 | 795 | 16.8 | 0.891 |
Congestive heart failure | 290 | 6.1 | 298 | 6.3 | 0.733 |
Chronic liver disease | 417 | 8.8 | 432 | 9.1 | 0.590 |
Chronic kidney disease | 293 | 6.2 | 294 | 6.2 | 0.966 |
Osteoporosis | 206 | 4.4 | 215 | 4.5 | 0.654 |
Malignancy | 214 | 4.5 | 216 | 4.6 | 0.921 |
Dementia | 202 | 4.3 | 207 | 4.4 | 0.800 |
Depression | 194 | 4.1 | 191 | 4.0 | 0.876 |
Epilepsy | 63 | 1.3 | 66 | 1.4 | 0.790 |
Parkinsonism | 126 | 2.7 | 116 | 2.5 | 0.515 |